Leishmaniasis in humans: drug or vaccine therapy?

M Ghorbani, R Farhoudi - Drug design, development and therapy, 2017 - Taylor & Francis
Leishmania is an obligate intracellular pathogen that invades phagocytic host cells.
Approximately 30 different species of Phlebotomine sand flies can transmit this parasite …

Tackling drug resistance and other causes of treatment failure in leishmaniasis

GJ Wijnant, F Dumetz, L Dirkx, D Bulté… - Frontiers in Tropical …, 2022 - frontiersin.org
Leishmaniasis is a tropical infectious disease caused by the protozoan Leishmania parasite.
The disease is transmitted by female sand flies and, depending on the infecting parasite …

Amphotericin B resistance in Leishmania mexicana: Alterations to sterol metabolism and oxidative stress response

EA Alpizar-Sosa, NRB Ithnin, W Wei… - PLoS Neglected …, 2022 - journals.plos.org
Amphotericin B is increasingly used in treatment of leishmaniasis. Here, fourteen
independent lines of Leishmania mexicana and one L. infantum line were selected for …

The enemy within: Targeting host–parasite interaction for antileishmanial drug discovery

S Lamotte, GF Späth, N Rachidi… - PLoS neglected tropical …, 2017 - journals.plos.org
The state of antileishmanial chemotherapy is strongly compromised by the emergence of
drug-resistant Leishmania. The evolution of drug-resistant phenotypes has been linked to …

Arginase and its mechanisms in Leishmania persistence

G Pessenda, JS da Silva - Parasite immunology, 2020 - Wiley Online Library
Leishmaniasis is a neglected infectious disease with clinical presentations ranging from
asymptomatic or mild symptoms to chronic infection and eventual death. The mechanisms of …

Regulation of Translation in the Protozoan Parasite Leishmania

ZN Karamysheva, SA Gutierrez Guarnizo… - International journal of …, 2020 - mdpi.com
Leishmaniasis represents a serious health problem worldwide and drug resistance is a
growing concern. Leishmania parasites use unusual mechanisms to control their gene …

Molecular targets and pathways for the treatment of visceral leishmaniasis

V Jain, K Jain - Drug discovery today, 2018 - Elsevier
Highlights•Visceral leishmaniasis is a complicated infectious disease.•Emerging resistance
is one of the main complications in treatment visceral leishmaniasis.•A comprehensive …

sCD163 levels as a biomarker of disease severity in leprosy and visceral leishmaniasis

RLL Silva, MB Santos, PLS Almeida… - PLoS neglected …, 2017 - journals.plos.org
Background CD163, receptor for the haptoglobin–hemoglobin complex, is expressed on
monocytes/macrophages and neutrophils. A soluble form of CD163 (sCD163) has been …

Leishmania donovani-Induced Increase in Macrophage Bcl-2 Favors Parasite Survival

RK Pandey, S Mehrotra, S Sharma, RS Gudde… - Frontiers in …, 2016 - frontiersin.org
Members of the Bcl-2 family are major regulators of apoptosis in mammalian cells, and
hence infection-induced perturbations in their expression could result into elimination of the …

Nitric Oxide Resistance in Leishmania (Viannia) braziliensis Involves Regulation of Glucose Consumption, Glutathione Metabolism and Abundance of Pentose …

N Pinho, AC Bombaça, JR Wiśniewski, G Dias-Lopes… - Antioxidants, 2022 - mdpi.com
In American Tegumentary Leishmaniasis production of cytokines, reactive oxygen species
and nitric oxide (NO) by host macrophages normally lead to parasite death. However, some …